SB 235375

N/A

Report date: 2025/03/18 15:07:36
NME

Base Information

Drug NameSB 235375
Drug Alias NameSB 235375SB-235375
ClassificationSmall molecules
Mechanisms of ActionP38 mitogen-activated protein kinase inhibitors
TargetsP38 mitogen-activated protein kinase
Therapy Area/IndicationsPeripheral Nervous System DiseasesCough
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPeripheral Nervous System DiseasesCough

Other Information

ATC CodeN/A
Related LinksN/A